Based on the profound scientific acknowledge and rich research experience, the metabolic disease pharmacological research system. developed by TriApex can provide various metabolic pharmacology research services for clients requiring new drug discovery, including providing scientific ideas and suggestions, participating in research protocol design, implementation of research protocols, analysis and interpretation of experimental data, and collaborative development of new disease models.
Introduction of ServicesTriAepx has an advanced metabolic disease research platform, which can provide intravenous glucose tolerance test (IVGTT), oral glucose tolerance test (OGTT), oral mixed meal tolerance test (OMMTT), glucose gradient test (GGI), glucose clamp test (hyperinsulinemia - glycaemia), etc. At the same time, TriAepx has built a series of top testing technology platforms, including cardiac magnetic resonance imaging technology platform, CT coronary artery imaging technology platform, CT angiography technology (CTA) platform, to meet the requirements for real-time and accurate testing.
TriApex can provide relevant trial services targeting animal models of different metabolic diseases.
Type | Obesity model | Metabolic liver disease model |
Service | Food intake Water intake Fat biopsy Body fat distribution Oral lactose tolerance test Food/stool energy determination Body weight measurement Biomarker detection and gene expression Metabolic and lipid indicator collection | Biochemical and clinical chemical analysis Detection of hepatic steatosis based on ultrasound techniques Evaluation of liver stiffness based on ultrasound elastography Quantitative analysis of liver fat content, liver biopsy and histological evaluation based on MRI technology Biomarker detection and analysis |
Official WeChat account
Official video account
苏公网安备32011202001081 
Regulatory Policies
Project Management
Global
